Opening the book…
RNA abundance, protein abundance, and biological function
RNA abundance, protein abundance, and biological function are connected, but each measures a different endpoint. An RNA change may occur before a detectable protein change. Translation, protein turnover, secretion, metabolism, and cell loss can also affect the relationship. Plan collection times around the biological question and report when each measurement was made.
Interpreting different results
Consider a hypothetical resveratrol study in MSCs. Normalized NAMPT RNA increases, detected NAMPT protein changes little, and total NAD⁺ per well decreases. Viable cell number also decreases. Fewer contributing cells may partly explain the lower NAD⁺ amount per well, but additional measurements are needed to assess that explanation. Together, these findings describe several treatment-associated changes; they do not establish a single mechanism.
Similarly, a lower IL-6 concentration after exposing THP-1 cells to an MSC EV-enriched preparation has several possible explanations. These include reduced cytokine production or release, increased degradation or uptake, fewer viable cells, a different medium volume, or assay interference. Matched preparation controls, cell-health measurements, collection records, and matrix checks help distinguish these possibilities. Characterizing particles in the preparation does not, by itself, explain the cytokine response.

Connecting the source to the recipient
A source preparation and a recipient-cell response represent different parts of an experiment. Detecting NAMPT in an MSC preparation does not establish that NAMPT entered NHDFs or caused their response. That claim requires evidence connecting the preparation’s contents, recipient exposure or delivery, and the measured endpoint. Additional controls are needed to distinguish NAMPT activity from effects of other preparation components.
Troubleshooting an apparent knockdown
A treated sample produces a later target Cq than its control, but the reference Cq also shifts later and technical replicates disagree. This pattern does not yet support target-specific knockdown. Investigate RNA quality, RT input, inhibition, reference-gene stability, and reaction setup. Amplification in the no-RT control raises an additional concern about DNA contamination. Resolve failed controls and unexplained discrepancies before calculating or interpreting fold change.
Keeping the sample chain visible
A clear report connects each result to its source culture, collected fraction, processing history, assay controls, collection time, measurement units, and normalization. Present the measurements separately before explaining where they agree or differ. This approach helps readers judge the conclusion and identify the next experiment needed to test the remaining explanations.

Attribution: Images AI-generated using ChatGPT Modified by Emalee Mackenzie, Irvine Valley College. Licensed under CC BY-NC-SA
This page titled 14.11: Integrating Measurements Without Overstating Them was last modified on Wed, 21 Oct 2026 01:35:38 GMT and is shared under a CC BY-NC-SA 4.0 license and was authored, remixed, and/or curated by Emalee MacKenzie.
The book could not be loaded just now.